These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18665927)

  • 21. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
    Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
    Cadroy Y; Maraganore JM; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface.
    Diquélou A; Lemozy S; Dupouy D; Boneu B; Sakariassen K; Cadroy Y
    Blood; 1994 Oct; 84(7):2206-13. PubMed ID: 7919337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of thrombin activity with DNA-aptamers.
    Dobrovolsky AB; Titaeva EV; Khaspekova SG; Spiridonova VA; Kopylov AM; Mazurov AV
    Bull Exp Biol Med; 2009 Jul; 148(1):33-6. PubMed ID: 19902090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of single-stranded DNA molecules that bind and inhibit human thrombin.
    Bock LC; Griffin LC; Latham JA; Vermaas EH; Toole JJ
    Nature; 1992 Feb; 355(6360):564-6. PubMed ID: 1741036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
    Müller J; Freitag D; Mayer G; Pötzsch B
    J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
    Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.
    Tasset DM; Kubik MF; Steiner W
    J Mol Biol; 1997 Oct; 272(5):688-98. PubMed ID: 9368651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable 2'-substitution in the loop region of a thrombin-binding DNA aptamer.
    Awachat R; Wagh AA; Aher M; Fernandes M; Kumar VA
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1765-1768. PubMed ID: 29678465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.
    Pujadas-Mestres L; Lopez-Vilchez I; Arellano-Rodrigo E; Reverter JC; Lopez-Farre A; Diaz-Ricart M; Badimon JJ; Escolar G
    PLoS One; 2017; 12(2):e0171486. PubMed ID: 28192448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood.
    Kuijpers MJ; Nieuwenhuys CM; Feijge MA; Kloots W; Giesen PL; Jerling JC; oude Egbrink MG; Heemskerk JW
    Thromb Haemost; 2005 Jan; 93(1):97-105. PubMed ID: 15630498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.
    Zilberman-Rudenko J; Itakura A; Wiesenekker CP; Vetter R; Maas C; Gailani D; Tucker EI; Gruber A; Gerdes C; McCarty OJ
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):510-7. PubMed ID: 26769048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.
    Zwaginga JJ; IJsseldijk MJ; de Groot PG; Vos J; de Bos Kuil RL; Sixma JJ
    Arterioscler Thromb; 1991; 11(3):733-44. PubMed ID: 2029508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemically modified thrombin and anhydrothrombin that differentiate macromolecular substrates of thrombin.
    Hosokawa K; Ohnishi T; Kawakami A; Wakabayashi S; Koide T
    J Thromb Haemost; 2005 Dec; 3(12):2703-11. PubMed ID: 16246253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.